Repligen (RGEN) Tops Q3 EPS by 9c. Updates Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Repligen (RGEN) Tops Q3 EPS by 9c. Updates Guidance

Repligen Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Financial Guidance

November 1, 2022 7:30 AM EDT

Reports revenue of $200.7 million for the quarter, representing year-over-year growth of 13% as reported, 19% at constant currency and 16% organicDelivers base business growth of 29% for the quarterExpands Process Analytics portfolio with DRS Daylight Solutions agreement

WALTHAM, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its third quarter of 2022. Provided in this press release are financial highlights for the three- and nine- month periods ended September 30, 2022, updates... More